Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

118.02
+0.23000.20%
Post-market: 118.020.00000.00%16:04 EDT
Volume:817.79K
Turnover:96.50M
Market Cap:231.23B
PE:18.51
High:118.46
Open:117.24
Low:117.24
Close:117.79
Loading ...

Novartis Beats on Q1 Earnings and Sales, Raises Guidance, Stock Up

Zacks
·
29 Apr

Novartis Guidance Lift Seems Positive Signal for Investors -- Market Talk

Dow Jones
·
29 Apr

Novartis Surprises With Another Beat & Raise -- Market Talk

Dow Jones
·
29 Apr

Novartis's Guidance Lift Reflects Strong Sales -- Market Talk

Dow Jones
·
29 Apr

Novartis Q1 Core Earnings, Sales Rise; 2025 Outlook Set

MT Newswires Live
·
29 Apr

Novartis AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
29 Apr

Novartis Lifts Guidance After Profit, Sales Top Views -- Update

Dow Jones
·
29 Apr

Novartis Raises Forecast After Profit Beats Estimates

Bloomberg
·
29 Apr

Novartis Raises 2025 Outlook: Sales Now Seen Up High Single Digits (Prior Mid-To-High Single), Core Income Up Low Double Digits (Prior High Single To Low Double)

Benzinga
·
29 Apr

Novartis Q1 Adj. EPS $2.28 Beats $2.10 Estimate, Sales $13.23B Beat $13.12B Estimate

Benzinga
·
29 Apr

Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1

GlobeNewswire
·
29 Apr

Nvidia, Visa, Domino's, NXP: Stocks to watch today

Quartz
·
28 Apr

Amazon, Apple, Meta, Microsoft, Berkshire Hathaway, and Coca-Cola: Stocks to watch this week

Quartz
·
27 Apr

Market Chatter: Report Says 25% Pharma Tariff Would Raise US Drug Costs by $51 Billion Annually

MT Newswires Live
·
25 Apr

Report Says 25% Pharma Tariff Would Raise US Drug Prices by $51 Billion Annually, Reuters Reports

MT Newswires Live
·
25 Apr

Novartis Expected to Post Higher Profit, Sales -- Earnings Preview

Dow Jones
·
25 Apr

Novartis AG expected to post earnings of $2.13 a share - Earnings Preview

Reuters
·
25 Apr

Harrow Authorizes Nordic Group Unit to sell Generic Version of Maxitrol eye Treatment

MT Newswires Live
·
25 Apr

Novartis, Sanofi CEOs Say EU Should Hike Drug Prices to Boost Innovation

MT Newswires Live
·
23 Apr

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

Zacks
·
23 Apr